Seeking Alpha
 

Celsion Corporation (CLSN)

- NASDAQ
From other sites
Visit Seeking Alpha's
CLSN vs. ETF Alternatives
Company Description
Celsion Corpis a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.
Sector: Healthcare
Industry: Biotechnology
Country: United States